DANA SHAW: Open Payments
NPI 1871532101 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,265 in 126 payments from 23 companies in 2025. Trend: 2023 $2,281 · 2024 $2,406 · 2025 $2,265
Food & beverage: $2,265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $551 |
| PFIZER INC. | 16 | $233 |
| Amgen Inc. | 16 | $218 |
| ViiV Healthcare Company | 8 | $186 |
| Lilly USA, LLC | 11 | $158 |
| Gilead Sciences, Inc. | 6 | $107 |
| Corcept Therapeutics | 4 | $96 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
Products named: VRAYLAR, APRETUDE, NURTEC ODT, QULIPTA, MOUNJARO, OTEZLA, Korlym, REXULTI.
Industry payments across UT — which companies pay providers there.
